Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith

A compound of the formula:

• wherein:
• R1 is
• R2 is H, lower alkyl, halogen, or —OR9;
• R3 and R4 are independently H, lower alkyl, substituted lower alkyl, OR10, or NR11R12;
• n is an integer from 2-6;
• R5 and R6 are independently H, alkyl, substituted alkyl, or taken together with the N to which they are attached form a 4 to 7-membered heterocyclic or substituted heterocyclic ring optionally containing at least two heteroatoms;
• R7 and R8 are independently H, alkyl, or substituted alkyl;
• m is an integer from 1-3;
• L is —OC(═O)NH—, —O—, —C(═O)NH—, —NHC(═O)—, or —NHS(═O)2—;
• R9 is H or lower alkyl;
• R10 is H, alkyl, substituted alkyl, alkylamino, or substituted alkylamino;
• R11 and R12 are independently H, alkyl, or substituted alkyl;
• and
• Ar1 and Ar2 are independently aryl, substituted aryl, heteroaryl, or substituted heteroaryl,
• or a pharmaceutically acceptable salt thereof.